US Patent 12091442 Activatable cytokine constructs and related compositions and methods
Patent 12091442 was granted and assigned to CytomX Therapeutics on September, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12091442 Activatable cytokine constructs and related compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.